References
- 1UNAIDS. UNAIDS 2018 estimates. 2018. [cited 2019 December 23] DOI:
https://www.unaids.org/en/regionscountries/countries/uganda . - 2Benzekri NA, Seydi M. Doye IN, Toure M, Sy MP, Kiviat NB, et al. Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994–2015. PLoS ONE. 2019; 13(12):
e0208635 . DOI: 10.1371/journal.pone.0208635 - 3Kalyesubula R, Kayongo A, Semitala FC, Muhanguzi A, Katantazi N, Ayers D, et al. Trends and level of control of hypertension among adults attending an ambulatory HIV clinic in Kampala, Uganda: A retrospective study. BMJ Global Health. 2016; 1(3):
e000055 .https://gh.bmj.com/content/bmjgh/1/3/e000055.full.pdf . DOI: 10.1136/bmjgh-2016-000055 - 4Guwatudde D, Mutungi G, Wesonga R, Kajjura R, Kasule H, Muwonge J, et al. The Epidemiology of Hypertension in Uganda: Findings from the National Non-Communicable Diseases Risk Factor Survey 2015. PLoS ONE. 2015 Sep 25; 10(9):
e0138991 . DOI: 10.1371/journal.pone.0138991 - 5Nduka CU, Stranges S, Sarki AM, Kimani PK, Uthman OA. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: A systematic review with meta-analysis. Journal Of Human Hypertension. 2015; 30: 355. DOI: 10.1038/jhh.2015.97
- 6Kayima J, Nankabirwa J, Sinabulya I, Nakibuuka J, Zhu X, Rahman M, et al. Determinants of hypertension in a young adult Ugandan population in epidemiological transition—The MEPI-CVD survey. BMC Public Health. 2015; 15(1): 830. DOI: 10.1186/s12889-015-2146-y
- 7Kwarisiima D, Balzer L, Heller D, Kotwani P, Chamie G, Clark T, et al. Population-based assessment of hypertension epidemiology and risk factors among HIV-positive and general populations in rural Uganda. PLoS ONE. 2016; 11(5):
e0156309 . DOI: 10.1371/journal.pone.0156309 - 8Phalane E, Fourie CMT, Mels CMC, Schutte AE. A comparative analysis of blood pressure in HIV-infected patients versus uninfected controls residing in sub-Saharan Africa: A narrative review. Journal of Human Hypertension. 2020; 34(10): 692–708. DOI: 10.1038/s41371-020-0385-6
- 9Siddharthan T, Grigsby M, Morgan B, Kalyesubula R, Wise RA, Kirenga B, et al. Prevalence of chronic respiratory disease in urban and rural Uganda. Bulletin of the World Health Organization. 2019; 97(5): 318–27.
https://pubmed.ncbi.nlm.nih.gov/31551628 . DOI: 10.2471/BLT.18.216523 - 10Kayongo A, Wosu AC, Naz T, Nassali F, Kalyesubula R, Kirenga B, et al. Chronic obstructive pulmonary disease prevalence and associated factors in a setting of well-controlled HIV: A cross-sectional study. COPD. 2020: 1–9. DOI: 10.1080/15412555.2020.1769583
- 11Sato T, Matsuyama Y. Marginal structural models as a tool for standardization. Epidemiology. 2003; 14(6): 680–6. DOI: 10.1097/01.EDE.0000081989.82616.7d
- 12Xu Y, Chen X, Wang K. Global prevalence of hypertension among people living with HIV: A systematic review and meta-analysis. Journal of the American Society of Hypertension. 2017; 11(8): 530–40.
http://www.sciencedirect.com/science/article/pii/S1933171117301900 . DOI: 10.1016/j.jash.2017.06.004 - 13Kwarisiima D, Balzer L, Heller D, Kotwani P, Chamie G, Clark T, et al. Population-based assessment of hypertension epidemiology and risk factors among HIV-positive and general populations in rural Uganda. PLoS ONE. 2016; 11(5):
e0156309-e . DOI: 10.1371/journal.pone.0156309 - 14Ogunmola OJ, Oladosu OY, Olamoyegun AM. Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: A cross-sectional cohort study. Vasc Health Risk Manag. 2014; 10: 129–37.
https://pubmed.ncbi.nlm.nih.gov/24672244 . DOI: 10.2147/VHRM.S58449 - 15Zhang J, Crowley SD. Role of T lymphocytes in hypertension. Curr Opin Pharmacol. 2015; 21: 14–9. DOI: 10.1016/j.coph.2014.12.003
- 16Fahme SA, Bloomfield GS, Peck R. Hypertension in HIV-Infected Adults. Hypertension. 2018; 72(1): 44–55. DOI: 10.1161/HYPERTENSIONAHA.118.10893
- 17Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: A systematic review and meta-analysis. Lancet Infect Dis. 2010; 10(4): 251–61. DOI: 10.1016/S1473-3099(10)70026-8
- 18Baker JV, Hullsiek KH, Engen NW, Nelson R, Chetchotisakd P, Gerstoft J, et al. Early antiretroviral therapy at high CD4 counts does not improve arterial elasticity: A substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial. Open Forum Infect Dis. 2016; 3(4). DOI: 10.1093/ofid/ofw213
- 19World Health Organisation. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. 2010. [cited 2020 April 01].
https://www.who.int/hiv/pub/arv/adult2010/en/ . - 20World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. 2013. [cited 2020 April 01].
https://www.who.int/hiv/pub/guidelines/arv2013/download/en/ . - 21World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: What’s new. 2015. [cited 2020 April 01].
https://www.who.int/hiv/pub/arv/policy-brief-arv-2015/en/ . - 22Dimala CA, Kadia BM, Kemah B-L, Tindong M, Choukem S-P. Association between CD4 cell count and blood pressure and its variation with body mass index categories in HIV-infected patients. International Journal of Hypertension. 2018; 2018: 1691474.
https://pubmed.ncbi.nlm.nih.gov/29610680 . DOI: 10.1155/2018/1691474 - 23Manner IW, Baekken M, Oektedalen O, Os I. Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study. Blood Pressure. 2012; 21(5): 311–9. DOI: 10.3109/08037051.2012.680742
- 24Calò LA, Caielli P, Maiolino G, Rossi G. Arterial hypertension and cardiovascular risk in HIV-infected patients. Journal of Cardiovascular Medicine. 2013; 14(8): 553–8.
https://journals.lww.com/jcardiovascularmedicine/Fulltext/2013/08000/Arterial_hypertension_and_cardiovascular_risk_in.2.aspx . DOI: 10.2459/JCM.0b013e3283621f01 - 25Musinguzi G, Anthierens S, Nuwaha F, Van Geertruyden J-P, Wanyenze RK, Bastiaens H. Factors influencing compliance and health seeking behaviour for hypertension in Mukono and Buikwe in Uganda: A qualitative study. International Journal of Hypertension. 2018; 2018: 8307591.
https://www.ncbi.nlm.nih.gov/pubmed/29854433 . DOI: 10.1155/2018/8307591 - 26Church K, Kiweewa F, Dasgupta A, Mwangome M, Mpandaguta E, Gomez-Olive FX, et al. A comparative analysis of national HIV policies in six African countries with generalized epidemics. Bulletin of the World Health Organization. 2015; 93(7): 457–67. DOI: 10.2471/BLT.14.147215
- 27Manne-Goehler J, Siedner MJ, Montana L, Harling G, Geldsetzer P, Rohr J, et al. Hypertension and diabetes control along the HIV care cascade in rural South Africa. Journal of the International AIDS Society. 2019; 22(3):
e25213-e .https://www.ncbi.nlm.nih.gov/pubmed/28696346 . DOI: 10.1002/jia2.25213